drugset / Trial / NCT05886374
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety, tolerability and PK profile of HMPL-415S1 and determine MTD and/or RP2D in patients with advanced malignant solid tumor.
Timeline
- Start
- 2023-07-06
- Primary completion
- 2025-05-31
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HMPL-415S1 | Unknown | 0.5 mg | Oral |
| Subject | HMPL-415S1 | Unknown | 5 mg | Oral |
| Subject | HMPL-415S1 | Unknown | 25 mg | Oral |